Terms: = Breast cancer AND NDRG1, NDR1, 10397, ENSG00000104419, Q92597, RIT42, CMT4D, TARG1, HMSNL, GC4, RTP, TDD5, PROXY1, NMSL, CAP43 AND Diagnosis
4 results:
1. Mammostrat as a tool to stratify breast cancer patients at risk of recurrence during endocrine therapy.
Bartlett JM; Thomas J; Ross DT; Seitz RS; Ring BZ; Beck RA; Pedersen HC; Munro A; Kunkler IH; Campbell FM; Jack W; Kerr GR; Johnstone L; Cameron DA; Chetty U
Breast Cancer Res; 2010; 12(4):R47. PubMed ID: 20615243
[TBL] [Abstract] [Full Text] [Related]
2. Preclinical studies of molecular-targeting diagnostic and therapeutic strategies against breast cancer.
Fujii T; Yokoyama G; Takahashi H; Namoto R; Nakagawa S; Toh U; Kage M; Shirouzu K; Kuwano M
Breast Cancer; 2008; 15(1):73-8. PubMed ID: 18224398
[TBL] [Abstract] [Full Text] [Related]
3. Hypoxia upregulates the expression of the ndrg1 gene leading to its overexpression in various human cancers.
Cangul H
BMC Genet; 2004 Sep; 5():27. PubMed ID: 15341671
[TBL] [Abstract] [Full Text] [Related]
4. Enhanced expression of a novel protein in human cancer cells: a potential aid to cancer diagnosis.
Cangul H; Salnikow K; Yee H; Zagzag D; Commes T; Costa M
Cell Biol Toxicol; 2002; 18(2):87-96. PubMed ID: 12046693
[TBL] [Abstract] [Full Text] [Related]
